BNP Paribas Financial Markets
DMTX

BNP Paribas Financial Markets’s Dimension Therapeutics, Inc DMTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-72
Closed -$126 – 4437
2017
Q1 		$126 Sell
72
-537
-88% -$1.42K ﹤0.01% 3989
2016
Q4 		$2.65K Sell
609
-114
-16% -$607 ﹤0.01% 3872
2016
Q3 		$5.78K Buy
723
+216
+43% +$1.56K ﹤0.01% 3357
2016
Q2 		$3.04K Buy
+507
New +$3.86K ﹤0.01% 3411
2016
Q1 		– Sell
-1,004
Closed -$11.3K – 3590
2015
Q4 		$11.3K Buy
+1,004
New +$12.7K ﹤0.01% 3386

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BNP Paribas Financial Markets's DMTX Position: Q2 2017 in Review

BNP Paribas Financial Markets sold out of Dimension Therapeutics, Inc (DMTX) in Q2 2017, closing a stake of 72 shares — an estimated $126 sold.

BNP Paribas Financial Markets first reported a position in DMTX in Q4 2015 and held it in 5 quarters. The position peaked at $11.3K in Q4 2015. 35 funds tracked by Wall St. Rank hold DMTX as of Q2 2017.

  • BNP Paribas Financial Markets reported no remaining Dimension Therapeutics, Inc position as of Q2 2017 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 72 Dimension Therapeutics, Inc shares in Q2 2017, an estimated $126.
  • BNP Paribas Financial Markets first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 5 quarters.
  • BNP Paribas Financial Markets's Dimension Therapeutics, Inc position peaked at $11.3K in Q4 2015.
  • 35 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q2 2017.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2017, filed 3 Aug 2017.